20th Call for proposals 2020 - Innovative Medicines Initiative 2 Joint Undertaking - H2020-JTI-IMI2 H2020-JTI-IMI2-2020-20-two-stage Closed!


The Innovative Medicines Initiative 2 Joint Undertaking (IMI2 JU) has been created following the principles below:

  • Research related to the future of medicine should be undertaken in areas where societal, public health and biomedical industry competitiveness goals are aligned and require the pooling of resources and greater collaboration between the public and private sectors, with the involvement of Small- and Medium- sized Enterprises (SMEs).
  • The scope of the initiative should be expanded to all areas of life science research and innovation.
  • The areas should be of public health interest, as identified by the World Health Organisation (WHO) report on priority medicines for Europe and the World


This call covers the following topics:

  • IMI2-2020-20-01: Early diagnosis, prediction of radiographic outcomes and development of rational, personalised treatment strategies to improve long-term outcomes in psoriatic arthritis
  • IMI2-2020-20-02: Innovations to accelerate vaccine development vaccine development and manufacture
  • IMI2-2020-20-03: Academia and industry united innovation and treatment for tuberculosis (UNITE4TB)
  • IMI2-2020-20-04: Tumour plasticity
  • IMI2-2020-20-05: Proton versus photon therapy for oesophageal cancer - a trimodality strategy
  • IMI2-2020-20-06: Handling of protein drug products and stability concerns

European community funding

The Community provisional funding available for the call for proposals is:

  • 273,22 Million EUR (Global Budget)

All the important deadlines

  • 21 April 2020 - more than one year ago (Deadline for the presentation of proposals)
  • 05 November 2020 - 10 months ago (Deadline for the presentation of proposals)

Further information about the call

Official webpage of the call

Useful documents

  • Call for Proposals (Legal base)

Organisations eligible to participate

Opened to the following bodies or institutes with legal status established in the covered areas:

  • Any legal organisation

Covered areas

Bodies or institutes must have their registered legal seat in one of the countries taking part in the Programme which are:

  • European Union (EU)

Directorate-Generale responsible

Directorate-General for Research

Related calls for proposals

Related calls

Explore other programmes